Tag: orphan drug protection
Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection
Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, encouraging development where profits are low. Learn how it works, why it's controversial, and how it's shaping the future of medicine.